Demographics table of patients with CTCL
| Characteristic . | Value, N = 11 . |
|---|---|
| Demographic and clinical features | |
| Sex, n (%) | |
| Male | 7 (64) |
| Female | 4 (36) |
| Age | |
| Mean, y (SD) | 70 (12) |
| Range, y | 46-82 |
| Race, n (%) | |
| White | 10 (91) |
| Black | 1 (9) |
| MF/SS diagnosis | |
| SS, n (%) | 8 (73) |
| MF, n (%) | 3 (27) |
| Stage at collection | |
| IA | 3 |
| IB | 1 |
| IIA | 1 |
| IIB | |
| III | |
| IV | 6 |
| MF/SS present in blood, # cells per μL | |
| SS, mean (range) | 2345 (484-57640) |
| MF, mean (range) | 107 (0-310) |
| Prior or coexisting neoplasm, # patients % | |
| Solid tumor | 1 (9) |
| Myeloid tumor | 2 (18) |
| Characteristic . | Value, N = 11 . |
|---|---|
| Demographic and clinical features | |
| Sex, n (%) | |
| Male | 7 (64) |
| Female | 4 (36) |
| Age | |
| Mean, y (SD) | 70 (12) |
| Range, y | 46-82 |
| Race, n (%) | |
| White | 10 (91) |
| Black | 1 (9) |
| MF/SS diagnosis | |
| SS, n (%) | 8 (73) |
| MF, n (%) | 3 (27) |
| Stage at collection | |
| IA | 3 |
| IB | 1 |
| IIA | 1 |
| IIB | |
| III | |
| IV | 6 |
| MF/SS present in blood, # cells per μL | |
| SS, mean (range) | 2345 (484-57640) |
| MF, mean (range) | 107 (0-310) |
| Prior or coexisting neoplasm, # patients % | |
| Solid tumor | 1 (9) |
| Myeloid tumor | 2 (18) |
Overall demographics of sex, age, race, diagnosis, stage, and prior or existing neoplasms independent of CTCL (n = 11).